GlassScriptPhysician profile
Jose Gomez
NPI 1336119429
$7,693.62
in general payments reported to CMS, 2019-2025
19 companies · $935 in 2025
The $935 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,940 · 2020: $567 · 2021: $1,124 · 2022: $1,207 · 2023: $784 · 2024: $1,136 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,855.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,344.99 | 2019-2025 | Jardiance |
| Medtronic, INC. | $1,122.70 | 2019-2025 | Linq II, Micra, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $878.20 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $655.97 | 2019-2024 | Lokelma, Farxiga |
| Boston Scientific Corporation | $648.50 | 2020-2025 | Watchman Flx, Emblem Mri S-Icd, Opticross |
| E.R. Squibb & Sons, L.L.C. | $614.11 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $598.97 | 2019-2021 | |
| Edwards Lifesciences Corporation | $398.10 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $373.49 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $199.58 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $170.24 | 2020-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $157.83 | 2019-2021 | |
| Johnson and Johnson International | $151.86 | 2021-2024 | Carto 3 |
| Sanofi-Aventis U.S. LLC | $120.86 | 2019 | |
| Amgen INC. | $99.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $99.54 | 2020 | |
| Biotronik INC. | $24.48 | 2019 | |
| Cordis US Corp. | $21.40 | 2022 | |
| Cardinal Health P.R. 120 INC | $12.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.